Evidence map›Paper›PMID 25405988›Full record

ArticlePloS one2014

Development and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South Africa.

Jason E Farley, Ana M Kelly, Katrina Reiser, Maria Brown, Joan Kub, Jeane G Davis, Louise Walshe, Martie Van der Walt

2 registry-linked trialsOpen access · goldAbstract readEvaluation Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02707991 nacompletednot on this mapstarted 2016, after this paper: background citation

Nurse Case Management to Improve Linkage to Hepatitis C Care and Treatment Initiation in HIV Co-infection: A Randomized Controlled Trial

TypeinterventionalSponsorJohns Hopkins UniversityRan2016 to 2018Enrolled68ConditionsHIV, Hepatitis C, ChronicArmsNurse Case Management
NCT04298905 naactive not recruitingnot on this mapstarted 2022, after this paper: background citation

Leveraging mHealth to Enable and Adapt Community Health Worker Strategies to Improve TB/HIV Patient Outcomes in South Africa (LEAP-TB-SA) Trial

TypeinterventionalSponsorJohns Hopkins UniversityRan2022 to 2026Enrolled62ConditionsAdherence, Patient, TB, HIV/AIDS, Care CoordinationArmsCHW mHealth patient intervention for trigger escalation
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Exploring HIV disease indicators at MDR-TB treatment initiation in South Africa.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2024
    Trial
  3. Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2020
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Aminoglycoside-induced Hearing Loss Among Patients Being Treated for Drug-resistant Tuberculosis in South Africa: A Prediction Model.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  18. Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jason E FarleySchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Ana M KellyCollege of Nursing, Michigan State University, East Lansing, Michigan, United States of America.
Katrina ReiserSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Maria BrownSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Joan KubSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
Jeane G DavisSchool of Nursing, Johns Hopkins University, Baltimore, Maryland, United States of America.
Louise WalsheBloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
Martie Van der WaltTuberculosis Epidemiology and Intervention Research Unit, Medical Research Council, Pretoria, South Africa.
Johns Hopkins University · USMichigan United · USSouth African Medical Research Council · ZA

Funding

A Nurse Case Management Intervention to Improve MDR-TB/HIV Coinfection OutcomesR01AI104488 · NIAID · JOHNS HOPKINS UNIVERSITY · PI FARLEY, JASON EDWARD · 2014 to 2019
$3.2M
NIAID NIH HHS 1R01AI104488-01NIAID NIH HHS R01 AI104488
6 · The paper itself

Abstract

settingMultidrug-resistant tuberculosis (MDR-TB) unit in KwaZulu-Natal, South Africa.

objectiveTo develop and evaluate a nurse case management model and intervention using the tenets of the Chronic Care Model to manage treatment for MDR-TB patients with a high prevalence of human immunodeficiency virus (HIV) co-infection.

designA quasi-experimental pilot programme utilizing a nurse case manager to manage care for 40 hospitalized MDR-TB patients, 70% HIV co-infected, during the intensive phase of MDR-TB treatment. Patients were followed for six months to compare proximal outcomes identified in the model between the pre- and post-intervention period.

resultsThe greatest percent differences between baseline and six-month MDR-TB proximal outcomes were seen in the following three areas: baseline symptom evaluation on treatment initiation (95% improvement), baseline and monthly laboratory evaluations completed per guidelines (75% improvement), and adverse drug reactions acted upon by medical and/or nursing intervention (75% improvement).

conclusionImprovements were identified in guideline-based treatment and monitoring of adverse drug reactions following implementation of the nurse case management intervention. Further study is required to determine if the intervention introduced in this model will ultimately result in improvements in final MDR-TB treatment outcomes.

Indexed as

Models, NursingCase ManagementHIV InfectionsHumansNursesPilot ProjectsSouth AfricaTuberculosis, Multidrug-Resistant

Identifiers

PMID25405988
PMCPMC4236054
OpenAlexW2088423935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.